tradingkey.logo
tradingkey.logo
Search

Defiance Daily Target 2X Long MRNA ETF

MRNX
Add to Watchlist
208.204USD
+19.644+10.42%
Close 11-06 16:00(ET)
16.12KVolume
3.50MTurnover

Defiance Daily Target 2X Long MRNA ETF

208.204
+19.644+10.42%

Today

+10.42%

5 Days

+27.27%

1 Month

+45.63%

6 Months

+797.04%

Year to Date

0.00%

1 Year

0.00%

Key Figures

196.300Open
188.560Prev. Close
229.155High
184.000Low
16.12KVolume
3.50MTurnover
0.15Volume Ratio
229.15552wk High
14.95052wk Low
372.88KAvg Volume
--Div Yield
--Est. Annual Div.
Health CareInvestment Segment
NoInverse ETF
YesLeveraged ETF
2xLeverage Factor
134.358NAV
USDNAV Currency
--P/B
--Price to earnings ratio

Defiance Daily Target 2X Long MRNA ETF Profile

Ticker SymbolMRNX
Asset ClassEquity
Fund ManagerDefiance
DomicileUS
Expense Ratio1.34%
Founded at2026-02-03
Tracking Index--
MRNX was created on 2026-02-03 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. MRNX seeks to deliver 2x leveraged exposure to the daily share price movement of Moderna, Inc. (NASDAQ: MRNA), net fees and expenses, through derivatives like swap agreements. MRNA develops mRNA-based vaccines and therapies, best known for its COVID-19 vaccine.

Top 10 Holdings

No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
United States Treasury Bills 0%
B 0 11.19.26
--
0.000
--
12.85M
28.12%
$12.81M
First American Government Obligs X
FGXXX
--
0.000
--
955.59K
2.10%
$955.59K
1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy

Defiance Daily Target 2X Long MRNA ETF News

More news coming soon, stay tuned...

FAQs

What is the current price of Defiance Daily Target 2X Long MRNA ETF (MRNX)?

The current price of Defiance Daily Target 2X Long MRNA ETF (MRNX) is 208.20. Market data may be delayed; please refer to the timestamp displayed on the page.

What is the 52-week high of Defiance Daily Target 2X Long MRNA ETF?

The 52-week high of Defiance Daily Target 2X Long MRNA ETF is 229.16. Please refer to the page timestamp for the latest data.

What is the 52-week low of Defiance Daily Target 2X Long MRNA ETF?

The 52-week low of Defiance Daily Target 2X Long MRNA ETF is 14.95. Please refer to the page timestamp for the latest data.

What is the NAV of Defiance Daily Target 2X Long MRNA ETF?

The NAV of Defiance Daily Target 2X Long MRNA ETF is 134.36 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.

How is Defiance Daily Target 2X Long MRNA ETF (MRNX) performing?

The trading turnover of Defiance Daily Target 2X Long MRNA ETF (MRNX) is 3.50M. Its price changed by 26.21% over the past month, while its one-year return is 921.86%. View the Defiance Daily Target 2X Long MRNA ETF price chart for more details.

Is Defiance Daily Target 2X Long MRNA ETF (MRNX) a safe investment?

No investment is completely risk-free. The risk level of Defiance Daily Target 2X Long MRNA ETF (MRNX) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.